Insider Transactions

Robert Eifler, President and CEO of Noble Corp (NE) recently bought 12,568 shares. The buy increased his position by 1%, and came to a total cost of $350,019. He was joined by the company CFO, who bought 8,000 shares for just over $223,250, and who increased his position by 3%. A company director also bought 8,992 shares, increasing his stake by 31%. Going further back, insiders have been slight sellers of shares at higher prices. Overall, Noble Corp insiders own 21.4% of ...
Read More About This

Christopher Boerner, CEO of Bristol Myers Squibb (BMY), recently bought 2,000 shares. The buy increased his stake by 2%, and came to a total cost of $110,096. The CEO was also a buyer in late 2023 on multiple occasions. The latest buy came a week after a company EVP bought 1,823 shares, paying $100,000 for doing so. Going further back, company insiders have been net buyers since late 2023, and sellers earlier in 2023 at much higher share prices. Overall, Bristol Myers ...
Read More About This

Ruth Porat, a director at Blackstone (BX), recently bought 376 shares. The buy increased her stake by 1%, and came to a total cost of $61,926. Porat is a quarterly buyer of shares, and last bought in November, picking up 217 shares at a cost of less than $37,000. Otherwise, the company’s general council sold off 9% of his holdings for $7.45 million. Going further back, there’s been a similar mix of buyers and sellers. Overall, Blackstone insiders own 1.2% of shares. The ...
Read More About This

Michael Mahoney, a director at CVS Health (CVS), recently bought 30,000 shares. The buy increased his position by a massive 190%, and came to a total cost of just over $2 million. Mahoney was a buyer of over 9,100 shares last May, for just over $500,000. Another director also picked up 1,000 shares around the same period. Going back further, insiders were equally buyers and sellers of shares at a price near where CVS shares trade today. Overall, CVS Health insiders own ...
Read More About This

Philip Satre, a director at Wynn Resorts (WYNN), recently bought 22,200 shares. The buy increased his stake by a hefty 67%, and came to a total cost of just over $2.04 million. This marks the first insider buy at Wynn over the past two years. Insiders have been slight sellers of shares, with about half of sales occurring following the exercise of stock options. Sales include the company CEO and CFO. Overall, Wynn Resorts insiders own 27.1% of shares. The resort owner and ...
Read More About This

Christopher Bode, President and COO at Denny’s (DENN), recently bought 9,740 shares. The buy increased his stake by over 1,000%, and came to a total cost of $49,805. This marks the first insider buy since last June, when the company CFO bought 10,000 shares for just over $65,000. Going further back, insiders were more likely to be sellers, particularly in 2023, when shares traded for nearly twice as much as they do today. Overall, Denny’s insiders own 3.1% of shares. The diner chain ...
Read More About This

Charles Moorman, a director at Oracle (ORCL), recently bought 5,000 shares. The buy increased his stake by 7%, and came to a total cost of $947,913. This marks the first insider buy at the company in over two years. Otherwise, company insiders have been regular sellers of shares as the stock has taken off. Nearly all insider sales have come following the exercise of stock options, from company directors and VPs to the company’s CFO, and major holder Larry Ellison. Overall, Oracle ...
Read More About This

John Lindsay, President and CEO of Helmerich & Payne (HP), recently bought 20,000 shares. The buy increased his stake by 3%, and came to a total cost of $551,000. He was joined by a company director, who bought 37,356 shares for a hefty $1.01 million, increasing his position by a massive 217%. The company CFO bought 3,300 shares last year, starting a new position at a cost of just over $99,000. Otherwise, insiders have previously been sellers. Overall, Helmerich & Payne insiders ...
Read More About This